The use of a lithoclast probe for ureterorenoscopic coagulation of bleeding ureteral cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11257661.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe use of the lithoclast device, normally used for electrohydraulic stone fragmentation, for safe ureteroscopic intraureteral coagulation of a bleeding tumor. Intraureteral ureteroscopic coagulation of a bleeding transitional cell carcinoma was performed in an 86-year-old high risk patient. A 0.8 mm. probe of the lithoclast device was connected to high frequency current. To avoid short circuit to the ureteroscope the probe was covered with a standard 5Fr ureteral catheter, which served as a perfect isolator. The bleeding intraureteral tumor was coagulated successfully under direct vision. The lithoclast probe in combination with a standard ureteral catheter can be used for intraureteral coagulation of bleeding tumors. It is an inexpensive device that is often available in nonuniversity departments.
Medical subject headings
- Carcinoma, Transitional Cell
- Ureteral Neoplasms
- Urologic Surgical Procedures